CDX2, COX2 and MUC2 Expressions in Barrett's Esophagus: Can They Be Useful in Determination of the Dysplasia?

Turk Patoloji Dergisi - Turkey
doi 10.5146/tjpath.2012.01132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Federation of Turkish Pathology Societies

Related search

Affinity Peptide for Targeted Detection of Dysplasia in Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2010English

Does the Treatment of Proton Pump Inhibitors Reduce Dysplasia or Adenocarcinoma Development in Barrett's Esophagus?

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Fluorescence, Reflectance, and Light-Scattering Spectroscopy for Evaluating Dysplasia in Patients With Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2001English

MicroRNAs in Barrett's Esophagus and Esophageal Adenocarcinoma

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2009English

Session I: Barrett's Esophagus

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2006English

Barrett's Esophagus: Diagnosis and Management

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2017English

MicroRNA-196a Is a Potential Marker of Progression During Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus

American Journal of Pathology
Forensic MedicinePathology
2009English

Surgical Sympathectomy: Can It Be Useful in Cardiology?

Clinics
Medicine
2020English

Platelet 12-Lipoxygenase and Stem Cells in Barrett's Esophagus

Oncology Letters
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy